diazepam has been researched along with alprazolam in 212 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 71 (33.49) | 18.7374 |
| 1990's | 56 (26.42) | 18.2507 |
| 2000's | 34 (16.04) | 29.6817 |
| 2010's | 37 (17.45) | 24.3611 |
| 2020's | 14 (6.60) | 2.80 |
| Authors | Studies |
|---|---|
| Gall, M; Hester, JB; Lahti, RA; Rudzik, AD | 1 |
| Chidester, C; Duchamp, DJ; Gall, M; Lahti, RA; Rudzik, AD; Scahill, T | 1 |
| Collins, RJ; Gall, M; Kamdar, BV | 1 |
| Hester, JB; Von Voigtlander, P | 1 |
| Walser, A; Zenchoff, G | 1 |
| Evenson, GN; Hester, JB; VonVoigtlander, P | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Artursson, P; Mateus, A; Matsson, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ganeshpurkar, A; Gupta, SK; Gutti, G; Krishnamurthy, S; Kumar, D; Modi, G; Singh, SK | 1 |
| Rai, SN; Shankar, S; Sharma, P; Shrivastava, SK; Singh, SP; Srivastava, P; Srivastava, RK; Tripathi, PN | 1 |
| Carmona, AV; Kumari, S; Tiwari, AK; Trippier, PC | 1 |
| Ahmed, T; Cook, JM; Golani, LK; Mondal, P; Pandey, KP; Rezvanian, S; Sharmin, D; Witkin, JM; Yeunus Mian, M | 1 |
| Jaiswal, S; Raja Ayyannan, S; Tiwari, V; Uniyal, A | 1 |
| Aamir Javed, M; Ikram, M; Jadoon, R; Mahnashi, MH; Rashid, U; Sadiq, A; Saeed Jan, M; Shahid, M | 1 |
| Busto, UE; Kaplan, HL; Sellers, EM | 1 |
| Loeffler, PM | 1 |
| Cannizzaro, C; Cannizzaro, G; Flugy, A; Gagliano, M; Novara, V | 1 |
| Cowley, DS; Greenblatt, DJ; Hommer, D; Kramer, GL; Petty, F; Roy-Byrne, PP | 1 |
| Bouhours, P; Danjou, P; Hergueta, T; Lacomblez, L; Puech, AJ; Warot, D | 1 |
| Ahrens, TN; Baumgartner, WA; Cutler, NR; Hill, VA; Sramek, JJ | 1 |
| Cohen, MH; Johnston-Anderson, A; Krasnow, SH; Wadleigh, RG | 1 |
| al-Tikriti, MS; Baldwin, RM; Innis, RB; Johnson, EW; Laruelle, MA; Malison, RT; Seibyl, JP; Sybirska, EH; Zimmermann, RC; Zoghbi, SS | 1 |
| Franklin, SR; Tang, AH | 1 |
| Coppola, A; Francis, E; Sheehan, DV; Sheehan, MF; Torres, A | 1 |
| Boix, F; Escorihuela, RM; Fernández Teruel, A; Tobeña, A | 1 |
| Altamura, M; Cannuscio, B; Covelli, V; Decandia, P; Jirillo, E; Maffione, AB; Munno, I | 1 |
| Cannuscio, B; Covelli, V; Jirillo, E; Maffione, AB | 1 |
| Cocores, J | 1 |
| Boix, F; Escorihuela, RM; Fernández-Teruel, A; Tobena, A | 1 |
| Biggio, G; Concas, A; Mascia, MP; Sanna, E; Santoro, V; Serra, M | 1 |
| Apelt, S; Emrich, HM; Schmauss, C | 3 |
| Burrows, GD; Judd, FK; Marriott, PF; Norman, TR | 1 |
| Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Pieri, L; Schoch, P | 1 |
| Bartel, PR; Becker, PJ; Blom, MW; de Sommers, K; Van der Meyden, CH | 1 |
| Klerman, GL | 1 |
| Cook, B; Garvey, MJ; Noyes, R; Suelzer, M | 1 |
| Juergens, S | 1 |
| Eckardt, MJ; Granger, A; Lane, E; Linnoila, M; Lister, R; Moss, H; Stapleton, JM | 1 |
| Cook, B; Garvey, M; Noyes, R; Summers, R | 1 |
| Kathol, RG; Lopez, AL; Noyes, R | 1 |
| Anderson, BJ; Brown, TC; Exarchos, H; Lee, K | 1 |
| Natelson, BH; Ottenweller, JE; Tapp, WN | 1 |
| De Souza, EB; Grigoriadis, DE; Pearsall, D | 1 |
| Engel, JA; Söderpalm, B | 1 |
| Gastfriend, DR; Rosenbaum, JF | 1 |
| Covington, EC; Rapport, DJ | 1 |
| Grover, E; Natelson, BH; Ottenweller, JE; Tapp, WN | 1 |
| Cook, B; Garvey, M; Noyes, R; Tollefson, G | 1 |
| Caddeo, S; Ecari, U; Pariante, F | 1 |
| Cowley, DS; Dager, SR; Dunner, DL; Roy-Byrne, PP; Vitaliano, P | 1 |
| Engel, JA; Eriksson, E; Söderpalm, B | 1 |
| Simson, PE; Weiss, JM | 1 |
| Abernethy, DR; Greenblatt, DJ; Morse, DS; Shader, RI | 1 |
| Davison, K; Farquharson, RG; Khan, MC; Majid, A | 2 |
| Earley, B; Leonard, BE; O'Connor, WT | 1 |
| Ciancio, SG | 1 |
| Baker, RW; Zimmer, B; Zipursky, RB | 1 |
| Bjornsson, TD; Ellinwood, EH; Heatherly, DG; Kilts, C; Nikaido, AM | 1 |
| Aranko, K; Bordignon, D; Mattila, MJ | 1 |
| Alderdice, MT; Marunycz, JD; Napoliello, MJ; Newton, RE | 1 |
| Carlsson, M; Eriksson, E; Nilsson, C; Söderpalm, B | 1 |
| Geller, AM; Lucki, I; Rickels, K | 1 |
| Avery, DH; Dunner, DL; Hyde, TS; Ishiki, D; Wilson, LG | 1 |
| Cowley, DS; Dager, SR; Dunner, DL | 1 |
| Ellinwood, EH; Heatherly, DG; Nikaido, AM | 1 |
| Bjornsson, TD; Ellinwood, EH; Heatherly, DG; Nikaido, AM | 1 |
| Gallaher, EJ; Hollister, LE; Jacques, CJ | 1 |
| Albeck, JH | 1 |
| Coryell, W; Noyes, R | 1 |
| Cole, JO; Orzack, MH | 1 |
| Beake, B; Bird, M; Cole, JO; Dessain, E; Friedman, L; McEachern, J; Orzack, MH | 1 |
| Cagiano, R; Cuomo, V; De Salvia, MA; Maselli, MA; Racagni, G; Renna, G | 1 |
| Bell, J; Bickford-Wimer, PC; de la Garza, R; Egan, M; Freedman, R | 1 |
| Hata, T; Itoh, E; Kawabata, A; Kita, T; Nishimura, Y | 1 |
| Boix, F; Fernández Teruel, A; Tobeña, A | 1 |
| Csernansky, JG; Hollister, LE; Lombrozo, L; Overall, JE; Riney, SJ | 1 |
| Amsterdam, JD; Chung, HR; Csanalosi, IB; Hurowitz, AM; Kaplan, M; London, J; Rickels, K; Wiseman, K | 1 |
| Patterson, WM | 1 |
| Cagen, LM; Chesney, CM; Pifer, DD | 1 |
| Batcha, KJ; Olson, SC; Votolato, NA | 1 |
| Baiguerra, G; Kostowski, W; Valzelli, L | 1 |
| Cohen, SA; Dement, WC; Seidel, WF; Wilson, L | 1 |
| Aranko, K | 1 |
| Maletzky, BM | 1 |
| Cohn, JB | 1 |
| Rickels, K | 1 |
| Harris, DW; Sethy, VH | 2 |
| Cohen, D; Csanalosi, I; Greisman, P; Harris, H; Rickels, K; Ross, HA; Werblowsky, J | 1 |
| Hodges, DH; Sethy, VH | 2 |
| Assenzo, JR; Shu, VS | 1 |
| Annable, L; Chouinard, G; Fontaine, R; Labonte, A | 1 |
| Brogden, RN; Dawson, GW; Jue, SG | 1 |
| Elie, R; Lamontagne, Y | 1 |
| Ator, NA; Brady, JV; Griffiths, RR; Lamb, RJ; Lukas, SE | 1 |
| Greenblatt, DJ; Ochs, HR; Verburg-Ochs, B | 1 |
| DeTurck, KH; Miller, J; Routzahn, BK; Vogel, WH | 1 |
| Johnson, BW; Valvani, SC; Yalkowsky, SH | 1 |
| Cooper, TB; Friedman, MJ; Harris, PQ; Stolk, JM | 1 |
| Bonnet, MH; Kramer, M; Roth, T | 1 |
| Aden, GC; Thein, SG | 1 |
| Kolin, IS; Linet, OI | 1 |
| Jenck, F; Martin, JR; Moreau, JL | 1 |
| Frantik, E; Horváth, M; Kozená, L | 1 |
| Cannizzaro, C; Cannizzaro, E; Cannizzaro, G; Gagliano, M; Mineo, A; Sabatino, M | 1 |
| Needleman, SB; Porvaznik, M | 1 |
| Cowley, DS; Greenblatt, DJ; Hommer, DW; Nemeroff, CB; Radant, A; Ritchie, JC; Roy-Byrne, PP | 1 |
| Kulkarni, SK; Sharma, K | 1 |
| Adinoff, B | 1 |
| Busto, U; Kaplan, HL; Sellers, EM; Zawertailo, L | 1 |
| Ciraulo, DA; DuPont, RL; Griffiths, RR; Kosten, TR; Romach, MK; Sellers, EM; Woody, GE | 1 |
| Britton, K; Hauger, RL; Irwin, M | 1 |
| Alburges, ME; Hunt, ME; Longlet, LL; Mahan, DR; Wamsley, JK | 1 |
| Fulton, M; Petty, F; Rush, AJ; Trivedi, MH | 1 |
| Griebel, G; Perrault, G; Sanger, DJ | 1 |
| Burrows, GD; Cook, BL; Garvey, MJ; Judd, FK; Marriott, P; Norman, TR; Noyes, R; Reich, JH | 1 |
| Mazurek, MF; Rosebush, PI | 1 |
| Maletta, GJ | 1 |
| Cannizzaro, C; Cannizzaro, E; Gagliano, M; Mangiapane, N | 1 |
| Barnhill, JG; Ciraulo, AM; Ciraulo, DA; Greenblatt, DJ; Knapp, C; Sarid-Segal, O; Shader, RI | 1 |
| Asahi, T; Kuribara, H | 1 |
| Barros, HM; Manitiu, A; Miczek, KA; Vivian, JA | 1 |
| Broderick, PA | 1 |
| Cannizzaro, C; Cannizzaro, E; Gagliano, M; Mineo, A | 1 |
| Berry, RA; Boezaart, AP; Laubscher, JJ; Nell, ML | 1 |
| Covelli, V; Jirillo, E; Maffione, AB; Nacci, C; Tatò, E | 1 |
| Matthews, J; Pollack, MH; Scott, EL | 1 |
| Bourin, M; Hascoët, M | 1 |
| Hemmersbach, P; Ragnar Norli, H; Rasmussen, KE; Reubsaet, KJ | 1 |
| Atta-Politou, J; Dona, A; Koutselinis, A; Parissi-Poulou, M | 1 |
| Adam, G; Cesura, AM; Dautzenberg, FM; Jenck, F; Kilpatrick, G; Kolczewski, S; Lundstrom, K; Martin, JR; Moreau, JL; Ouagazzal, AM; Poli, SM; Roever, S; Wichmann, J | 1 |
| Gatti, JE | 1 |
| Freeman, EW; Rickels, K | 1 |
| Carlson, JN; Glick, SD; Haskew, R; Jerussi, TP; Maisonneuve, IM; Wacker, J | 1 |
| Collins, DC; Lee, ML | 1 |
| Lapierre, YD | 1 |
| Bagaméri, A; Kulcsár, T; Lehoczky, O; Pulay, T; Sárosi, Z | 1 |
| Beigh, A; Mir, B; Naqib, A | 1 |
| Gomez, TH; Meisch, RA; Roache, JD | 1 |
| Groenink, L; Maes, RA; Olivier, B; Oosting, RS; Pattij, T; van der Gugten, J | 1 |
| Cannizzaro, C; Cannizzaro, E; Gagliano, M; Martire, M; Mineo, A; Provenzano, G; Steardo, L | 1 |
| Alvi, SN; Khalid, S; Parimala, P; Rao, RN | 1 |
| Isbister, GK; O'Regan, L; Sibbritt, D; Whyte, IM | 1 |
| Bucior, J; Foltyn, W; Jastrzebska-Okoń, K; Kempiński, M; Knopik, J; Tomczyk, A; Ziółko, E | 1 |
| Akiyoshi, J; Fujiki, M; Isogawa, K; Kobayashi, H; Kodama, K; Matsushita, H; Tanaka, Y; Tsutsumi, T | 1 |
| Cottler, L; Inciardi, JA; Kurtz, SP; Surratt, HL | 1 |
| Arias, JL; Conejo, NM; González-Pardo, H | 1 |
| Dickson, SJ; Irving, RC | 1 |
| Cook, JM; Duke, AN; Huang, S; Mattingly, BA; Platt, DM; Rowlett, JK; Yin, W | 1 |
| Galetin, A; Hallifax, D; Houston, JB | 1 |
| Kulvanich, P; Ongpipattanakul, B; Sila-on, W; Vardhanabhuti, N | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
| Arbanas, D; Arbanas, G; Dujam, K | 1 |
| Jogani, V; Misra, A; Naik, S; Porecha, S; shah, T | 1 |
| Dai, Z; Liang, X; Liu, W | 1 |
| Chronister, CW; Goldberger, BA; Merves, ML | 1 |
| Argyraki, M; Ekonomopoulou, MT; Iakovidou-Kritsi, Z; Polatoglou, E; Stephanidou-Stephanatou, J; Tsoleridis, CA | 1 |
| Brown, RE; Fontana, M; Fraser, LM; Holmes, A; Hussin, A; Lederle, L; O'Leary, TP; Ramos, A; Whittaker, A | 1 |
| Huemer, HP; Irschick, EU; Kitchen, M; Lassnig, C; Nowotny, N; Pavlic, M | 1 |
| Carlezon, WA; Meloni, EG; Myers, KM; Rudolph, U; Smith, KS; Van't Veer, A | 1 |
| Akritopoulou, K; Ekonomopoulou, MT; Iakovidou-Kritsi, Z; Mourelatos, C | 1 |
| Chen, H; Shen, M; Xiang, P | 1 |
| Buetler, J; Crestani, F; Koester, C; Masneuf, S | 1 |
| Adams, JL; Blaschke, T; Dell, RM; Der, JS; Finkle, WD; Greenland, S; Ridgeway, G; VanRiper, KB; Wang, Z | 1 |
| Amaral, VC; Campos, KF; Miguel, TT; Nunes-de-Souza, RL; Rico, JL | 1 |
| Mendes-Gomes, J; Nunes-de-Souza, RL; Rico, JL; Rodgers, RJ; Sorregotti, T | 1 |
| Krzek, J; Maślanka, A; Szlósarczyk, M; Wach, K; Żmudzki, P | 1 |
| El Zahaf, NA; Salem Elhwuegi, A | 1 |
| Arima, Y; Nagao, M; Namera, A; Shiraishi, H; Tajima, T; Torikoshi, A; Toubou, H | 1 |
| Bertol, E; Boscolo Berto, R; Favretto, D; Mannaioni, G; Mari, F; Vaiano, F | 1 |
| Christophersen, AS; Enger, A; Nordal, K; Vindenes, V; Øiestad, EL | 1 |
| Gong, L; Guo, C; Jiang, S; Shi, F; Tan, H | 1 |
| Manicke, NE; Zhang, C | 1 |
| Tandeter, H | 1 |
| Buckley, NA; Cairns, R; Pearson, SA; Schaffer, AL | 1 |
| Holm, KM; Johansen, SS; Linnet, K; Skov, L | 1 |
| Orlando, JM | 1 |
| Bachs, L; Birdal, M; Bruun, LD; Høiseth, G; Karinen, R; Kjeldstadli, K; Middelkoop, G; Temte, V; Øiestad, E | 1 |
| Aricescu, AR; Desai, R; Karia, D; Kotecha, A; Laverty, D; Malinauskas, T; Masiulis, S; Miller, KW; Pardon, E; Serna Martin, I; Steyaert, J; Uchański, T; Zivanov, J | 1 |
| Aug, I; Bregin, A; Innos, J; Mazitov, T; Philips, MA; Vasar, E | 1 |
| Amioka, E; Black, JC; Dargan, PI; Dart, RC; Haynes, CM; Hockenhull, J; Wood, DM | 1 |
| Kościelniak, P; Majda, A; Mrochem, K; Świądro, M; Wietecha-Posłuszny, R | 1 |
| Cherner, M; Grelotti, DJ; Heaton, RK; Letendre, S; Ma, Q; Saloner, R; Sundermann, EE; Tyree, G | 1 |
| Falcon, M; Fernadez-Lopez, L; Luna, A; Mancini, R; Pellegrini, M; Rotolo, M | 1 |
| Boy, D; Büttner, A; Kegler, R; Kolbe, V; Rentsch, D; Schmidt, B | 1 |
| Apollonio, LG; Huestis, MA; Kaspar, CK; Lavins, ES; Michel, HM; Mitchell-Mata, CL; Sofalvi, S | 1 |
| Johannsen, ML; Jørgensen, FS; Munkboel, CH; Styrishave, B | 1 |
| Christophoridis, C; Fytianos, K; Kouinoglou, N; Lazaridis, N; Mitsika, EE; Zacharis, CK | 1 |
| Araújo, JO; Bergamaschi, CC; de Andrade, NK; Guimarães, CC; Lopes, LC; Motta, RHL; Ramacciato, JC | 1 |
| Adhikari, S; Barron, LP; Bhatnagar, A; Bowes, DA; Coronado-Apodaca, KG; Driver, EM; Halden, RU; Kumar, R; Martínez-Ruiz, M; McCall, KL; Melchor-Martínez, EM; Ng, KT; Oyervides-Muñoz, MA; Parra-Saldivar, R; Piper, BJ; Smith, T; Sosa-Hernandez, JE | 1 |
| Andersson, L; Håkansson, A; Johnson, B; Walde, J | 1 |
| Guo, D; Kossintseva, I; Zloty, DM | 1 |
| Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
20 review(s) available for diazepam and alprazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.
Topics: Amides; Carbamates; Click Chemistry; Drug Design; Pyridines; Structure-Activity Relationship; Triazoles; Urea | 2020 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Treatment of intractable dyspnea: clinical and ethical issues.
Topics: Alprazolam; Codeine; Diazepam; Dyspnea; Ethics, Medical; Humans; Infusions, Intravenous; Morphine; Neoplasms; Promethazine; Randomized Controlled Trials as Topic | 1992 |
Effects of benzodiazepines on the immune system.
Topics: Alprazolam; Antibody Formation; Benzodiazepines; Diazepam; Humans; Immune System; Immunity, Cellular; Neuroimmunomodulation; Neuropeptides; Phagocytosis; Phobic Disorders; Psychotropic Drugs | 1991 |
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans; Panic; Risk Factors; Substance Withdrawal Syndrome | 1990 |
Alprazolam and diazepam: addiction potential.
Topics: Alprazolam; Diazepam; Humans; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Clonazepam; Diazepam; Drug Tolerance; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1987 |
Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
Topics: Adolescent; Adult; Alprazolam; Arousal; Diazepam; Euphoria; Female; Humans; Lorazepam; Male; Methaqualone; Risk Factors; Substance-Related Disorders | 1988 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Diazepam; Humans; Imipramine; Kinetics | 1984 |
Alprazolam and benzodiazepine dependence.
Topics: Adult; Alcoholism; Alprazolam; Benzodiazepines; Comorbidity; Diazepam; Female; Humans; Incidence; Male; Methadone; Middle Aged; Opioid-Related Disorders; Substance Abuse Detection; Substance-Related Disorders | 1993 |
Benzodiazepines as antidepressants: does GABA play a role in depression?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Chlordiazepoxide; Depressive Disorder; Diazepam; GABA Modulators; gamma-Aminobutyric Acid; Humans; Treatment Outcome | 1995 |
Stress, neuropsychiatric disorders and immunological effects exerted by benzodiazepines.
Topics: Adjuvants, Immunologic; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Diazepam; Humans; Immune System; Immunosuppressive Agents; Stress, Physiological | 1998 |
Alprazolam is relatively more toxic than other benzodiazepines in overdose.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Critical Care; Diazepam; Drug Overdose; Humans; Length of Stay; Middle Aged | 2004 |
Benzodiazepine metabolism: an analytical perspective.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Azepines; Benzodiazepines; Bromazepam; Chromatography, High Pressure Liquid; Diazepam; Humans; Lorazepam; Mass Spectrometry; Midazolam; Triazolam | 2008 |
[The present study situation and application prospect of nail analysis for abused drugs].
Topics: Alprazolam; Azabicyclo Compounds; Chromatography, High Pressure Liquid; Cocaine; Diazepam; Eszopiclone; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Humans; Illicit Drugs; Nails; Piperazines; Specimen Handling; Substance Abuse Detection | 2010 |
Postmortem Brain and Blood Reference Concentrations of Alprazolam, Bromazepam, Chlordiazepoxide, Diazepam, and their Metabolites and a Review of the Literature.
Topics: Alprazolam; Blood-Brain Barrier; Bromazepam; Chlordiazepoxide; Diazepam; Forensic Toxicology; Humans | 2016 |
Effectiveness and safety of oral sedation in adult patients undergoing dental procedures: a systematic review.
Topics: Adult; Alprazolam; Anesthesia; Benzodiazepines; Diazepam; Humans; Midazolam | 2021 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
49 trial(s) available for diazepam and alprazolam
| Article | Year |
|---|---|
Abuse liability of bretazenil and other partial agonists.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Double-Blind Method; Humans; Male; Receptors, GABA-A; Substance-Related Disorders | 1992 |
Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; gamma-Aminobutyric Acid; Humans; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales | 1992 |
Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses.
Topics: Acoustic Stimulation; Adult; Alprazolam; Anxiety; Diazepam; Double-Blind Method; Feedback; Flicker Fusion; Humans; Male; Memory; Psychomotor Performance; Reaction Time; Ritanserin; Stress, Psychological | 1992 |
Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Substance-Related Disorders | 1990 |
Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Drug Administration Schedule; Humans; Panic; Risk Factors; Substance Withdrawal Syndrome | 1990 |
The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG.
Topics: Administration, Oral; Adult; Affect; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Electroencephalography; Flicker Fusion; Humans; Male; Psychomotor Performance; Saccades | 1990 |
Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Female; Half-Life; Humans; Male; Panic; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Recurrence; Substance Withdrawal Syndrome | 1991 |
Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
Topics: Adult; Affect; Alprazolam; Anxiety; Autonomic Nervous System; Cognition; Diazepam; Drug Interactions; Ethanol; Female; Humans; Nordazepam; Norepinephrine; Psychomotor Performance | 1990 |
Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Benzodiazepines; Depression; Diazepam; Fear; Female; Humans; Hydrocortisone; Male; Middle Aged; Panic; Phobic Disorders | 1990 |
Oral premedication in children: a comparison of chloral hydrate, diazepam, alprazolam, midazolam and placebo for day surgery.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Attitude; Child Behavior; Child, Preschool; Chloral Hydrate; Diazepam; Double-Blind Method; Female; Humans; Infant; Male; Midazolam; Placebos; Preanesthetic Medication; Random Allocation; Time Factors | 1990 |
Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
Topics: Adult; Alprazolam; Anxiety Disorders; Consumer Behavior; Depression; Diazepam; Double-Blind Method; Female; Humans; Middle Aged; Randomized Controlled Trials as Topic; Tranquilizing Agents | 1989 |
Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
Topics: Adult; Alprazolam; Anxiety; Diazepam; Double-Blind Method; Fear; Female; Humans; Male; Middle Aged; Panic; Placebos; Recurrence; Test Anxiety Scale; Time Factors | 1989 |
Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Dextropropoxyphene; Diazepam; Drug Interactions; Female; Half-Life; Humans; Kinetics; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged | 1985 |
A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Time Factors | 1985 |
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Receptors, GABA-A | 1985 |
Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Psychomotor Performance; Receptors, GABA-A | 1985 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Fear; Female; Humans; Male; Panic; Placebos; Psychiatric Status Rating Scales | 1986 |
Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Cognition; Diazepam; Humans; Lorazepam; Male; Psychomotor Performance | 1987 |
Placebo response in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dexamethasone; Diazepam; Double-Blind Method; Fear; Female; Humans; Hydrocortisone; Male; Panic; Placebos; Psychiatric Status Rating Scales | 1988 |
Potential for abuse of alprazolam.
Topics: Alprazolam; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Lorazepam; Methaqualone; Random Allocation; Substance-Related Disorders | 1988 |
Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.
Topics: Adolescent; Adult; Alprazolam; Arousal; Diazepam; Euphoria; Female; Humans; Lorazepam; Male; Methaqualone; Risk Factors; Substance-Related Disorders | 1988 |
Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.
Topics: Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1988 |
Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Topics: Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Diazepam; Double-Blind Method; Female; Humans; Imipramine; Male; Personality Inventory; Placebos; Psychiatric Status Rating Scales | 1987 |
Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjects.
Topics: Adult; Alprazolam; Benzodiazepines; Diazepam; Electroencephalography; Electrooculography; Female; Humans; Male; Psychomotor Performance; Sleep; Sleep Stages; Time Factors | 1985 |
Task-dependent development of cross-tolerance to psychomotor effects of lorazepam in man.
Topics: Adult; Alprazolam; Benzodiazepines; Diazepam; Drug Tolerance; Female; Humans; Lorazepam; Male; Nitrazepam; Psychomotor Performance; Temazepam | 1985 |
Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Middle Aged; Placebos; Psychiatric Status Rating Scales; Triazoles | 1980 |
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Middle Aged; Placebos; Time Factors | 1981 |
Recent advances in anxiolytic therapy.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Pyrimidines; Random Allocation | 1981 |
A controlled clinical trial of alprazolam for the treatment of anxiety.
Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales | 1983 |
Use of statistics in the analysis of side effect data from clinical trials of psychoactive agents.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Imipramine; Psychotropic Drugs; Statistics as Topic | 1982 |
A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1983 |
New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Bromazepam; Clinical Trials as Topic; Clonazepam; Diazepam; Humans; Panic; Receptors, Cell Surface; Receptors, GABA-A; Recurrence; Substance Withdrawal Syndrome | 1983 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Diazepam; Humans; Imipramine; Kinetics | 1984 |
Alprazolam and diazepam in the treatment of generalized anxiety.
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation | 1984 |
A dose response study of the hypnotic effectiveness of alprazolam and diazepam in normal subjects.
Topics: Adolescent; Adult; Alprazolam; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Humans; Hypnotics and Sedatives; Male; Sleep; Sleep Stages; Sleep, REM; Time Factors | 1981 |
Alprazolam compared to diazepam and placebo in the treatment of anxiety.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety; Benzodiazepines; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Triazoles | 1980 |
Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Topics: Adolescent; Adult; Aged; Alcoholism; Alprazolam; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome | 1981 |
Vigilance impairment after a single dose of benzodiazepines.
Topics: Acoustic Stimulation; Adult; Alprazolam; Arousal; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nitrazepam; Psychiatric Status Rating Scales; Time Factors | 1995 |
Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Alprazolam; Blood Pressure; Clonidine; Diazepam; Double-Blind Method; Ethanol; Female; Heart Rate; Humans; Male; Middle Aged; Neurologic Examination; Receptors, GABA-A | 1994 |
Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
Topics: Adult; Alprazolam; Analysis of Variance; Benzodiazepinones; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Male; Memory; Middle Aged; Psychomotor Performance; Substance-Related Disorders | 1994 |
Diazepam versus alprazolam for the treatment of panic disorder.
Topics: Adult; Age of Onset; Alprazolam; Diazepam; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Panic Disorder; Personality Inventory; Placebos; Research Design; Severity of Illness Index; Treatment Outcome | 1996 |
Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.
Topics: Adult; Affect; Alcoholism; Alprazolam; Anti-Anxiety Agents; Buspirone; Diazepam; Electrocardiography; Humans; Male; Substance-Related Disorders | 1997 |
Evaluation of anxiolysis and pain associated with combined peri- and retrobulbar eye block for cataract surgery.
Topics: Aged; Alprazolam; Anesthesia, Local; Anesthetics, Local; Anti-Anxiety Agents; Anxiety; Bromazepam; Bupivacaine; Cataract Extraction; Catheterization, Peripheral; Diazepam; Double-Blind Method; Eye; Humans; Injections; Lidocaine; Pain; Patient Satisfaction; Placebos; Preanesthetic Medication | 1998 |
A modified simple and rapid reversed phase liquid chromatographic method for quantification of diazepam and nordiazepam in plasma.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Calibration; Chromatography, High Pressure Liquid; Diazepam; Female; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Middle Aged; Nordazepam; Reference Standards; Reproducibility of Results; Solvents | 1999 |
Prior benzodiazepine exposure and benzodiazepine treatment outcome.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Medical Records; Placebos; Premenstrual Syndrome; Prospective Studies; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome | 2000 |
A comparative evaluation of the effects of oral lorazepam, alprazolam and diazepam on venous admixture.
Topics: Administration, Oral; Adult; Alprazolam; Blood Gas Analysis; Diazepam; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Preanesthetic Medication | 2002 |
[Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Depression; Diazepam; Female; Humans; Male; Middle Aged; Neoplasms; Psychiatric Status Rating Scales; Treatment Outcome | 2004 |
Efficacy and Safety of Anxiolytics in Mohs Micrographic Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Diazepam; Double-Blind Method; Gabapentin; Humans; Lorazepam; Melatonin; Mohs Surgery; Pregabalin | 2023 |
147 other study(ies) available for diazepam and alprazolam
| Article | Year |
|---|---|
Synthesis and pharmacology of novel anxiolytic agents derived from 2-[(dialkylamino)methyl-4H-triazol-4-yl] benzophenones and related heterocyclic benzophenones.
Topics: Animals; Anti-Anxiety Agents; Benzophenones; Drug Synergism; Electroshock; Ethanol; Male; Mice; Nicotine; Pentylenetetrazole; Semicarbazides; Strychnine; Triazoles | 1976 |
Novel anxiolytic agents derived from alpha-amino-alpha-phenyl-o-tolyl-4H-triazoles and -imidazoles.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Brain; Crystallography; Hypnotics and Sedatives; Imidazoles; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Models, Molecular; Molecular Conformation; Muscle Relaxation; Nicotine; Pentylenetetrazole; Rats; Seizures; Semicarbazides; Triazoles | 1978 |
Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Hydroxylation; Male; Methods; Mice; Oxidation-Reduction; Triazolam; Triazoles | 1978 |
6-Aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines. Influence of 1-substitution on pharmacological activity.
Topics: Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Body Temperature; Dextroamphetamine; Male; Mice; Motor Activity; Structure-Activity Relationship | 1979 |
Quinazolines and 1,4-benzodiazepines. 81. s-Triazolo[4,3-a][1,4]benzodiazepines by oxidative cyclization of hydrazones.
Topics: Animals; Benzodiazepines; Central Nervous System; Chemical Phenomena; Chemistry; Cyclization; Hydrazones; Mice; Oxidation-Reduction; Structure-Activity Relationship; Triazoles | 1977 |
6-(Substituted-amino)-4H-s-triazolo[4,3-a][1,4]benzodiazepines and 4-(substituted-amino)-6H-s-triazolo[4,3-a][1,4]benzodiazepines with potential antianxiety activity.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Isomerism; Male; Mice; Models, Molecular; Triazoles | 1980 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Diketopiperazines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Matrix Metalloproteinase 2; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2018 |
Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
Topics: Antioxidants; Benzoxazoles; Cholinesterase Inhibitors; Drug Design; Humans; Learning; Memory; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2019 |
Rationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies.
Topics: Alprazolam; Benzodiazepines; Chlorine; Diazepam; gamma-Aminobutyric Acid; Ion Channels; Ligands; Molecular Docking Simulation; Receptors, GABA; Receptors, GABA-A | 2022 |
Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones.
Topics: Amidohydrolases; Analgesics; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Monoacylglycerol Lipases; Neuralgia; Semicarbazones | 2022 |
Design, synthesis, in-vitro, in-vivo and ex-vivo pharmacology of thiazolidine-2,4-dione derivatives as selective and reversible monoamine oxidase-B inhibitors.
Topics: Hydrazones; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship; Thiazolidines | 2022 |
Antidepressant and anxiolytic effects of alprazolam versus the conventional antidepressant desipramine and the anxiolytic diazepam in the forced swim test in rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Depression; Desipramine; Diazepam; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Serotonin; Swimming | 1992 |
Detection of benzodiazepines in human hair by radioimmunoassay.
Topics: Adult; Alprazolam; Benzodiazepines; Diazepam; Female; Hair; Humans; Lorazepam; Male; Middle Aged; Radioimmunoassay | 1992 |
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves.
Topics: Alprazolam; Animals; Benzodiazepines; Brain; Brain Chemistry; Clonazepam; Diazepam; Female; Flumazenil; Injections, Intravenous; Macaca mulatta; Male; Papio; Receptors, GABA-A; Tomography, Emission-Computed, Single-Photon | 1991 |
The discriminative stimulus effects of diazepam in rats at two training doses.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Buspirone; Carbolines; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Flumazenil; Male; Morphine; Pentobarbital; Pyrazoles; Pyridazines; Rats; Rats, Inbred Strains; Triazolam | 1991 |
Snorting benzodiazepines.
Topics: Administration, Intranasal; Adult; Alprazolam; Anti-Anxiety Agents; Arousal; Bipolar Disorder; Diazepam; Female; Humans; Male; Personality Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Handling-habituation prevents the effects of diazepam and alprazolam on brain serotonin levels in rats.
Topics: Alprazolam; Animals; Arousal; Brain; Cerebral Cortex; Diazepam; Habituation, Psychophysiologic; Handling, Psychological; Hippocampus; Hydroxyindoleacetic Acid; Hypothalamus; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Synaptic Transmission | 1990 |
Alprazolam enhances the antibacterial activity exerted by normal human peripheral blood lymphocytes.
Topics: Adjuvants, Immunologic; Adult; Alprazolam; Antibody-Dependent Cell Cytotoxicity; Cytotoxicity Tests, Immunologic; Diazepam; Female; Humans; Male; Salmonella typhi; Stimulation, Chemical; T-Lymphocyte Subsets | 1991 |
Benzodiazepine withdrawal.
Topics: Alprazolam; Benzodiazepines; Diazepam; Humans; Substance Withdrawal Syndrome; Time Factors | 1991 |
Effects of different handling-stimulation procedures and benzodiazepines on two-way active avoidance acquisition in rats.
Topics: Alprazolam; Analysis of Variance; Animals; Anxiety; Avoidance Learning; Diazepam; Habituation, Psychophysiologic; Handling, Psychological; Male; Rats; Rats, Inbred Strains | 1991 |
"Ex vivo" binding of 35S-TBPS as a tool to study the pharmacology of GABAA receptors.
Topics: Alprazolam; Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Convulsants; Diazepam; Drug Synergism; Ethanol; In Vitro Techniques; Isoniazid; Male; Protein Conformation; Rats; Rats, Inbred Strains; Receptors, GABA-A; Stress, Physiological; Sulfur Radioisotopes; Valproic Acid | 1990 |
Physical dependence induced in DBA/2J mice by benzodiazepine receptor full agonists, but not by the partial agonist Ro 16-6028.
Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Drug Implants; Mice; Mice, Inbred DBA; Receptors, GABA-A; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1990 |
Panic disorder: strategies for long-term treatment.
Topics: Adolescent; Adult; Alprazolam; Anxiety Disorders; Diazepam; Female; Humans; Panic | 1991 |
Reduction of gastrointestinal symptoms following treatment for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Colonic Diseases, Functional; Diazepam; Fear; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Panic | 1990 |
Effects of chronic alprazolam treatment on plasma concentrations of glucocorticoids, thyroid hormones, and testosterone in cardiomyopathic hamsters.
Topics: Alprazolam; Animals; Cardiomyopathies; Cricetinae; Diazepam; Glucocorticoids; Male; Testosterone; Thyroid Hormones | 1989 |
Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Brain; Desipramine; Diazepam; Imipramine; Male; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, Corticotropin-Releasing Hormone; Receptors, Neurotransmitter; Receptors, Serotonin | 1989 |
Alpha 2-adrenoceptor antagonists potentiate the anticonflict and the rotarod impairing effects of benzodiazepines.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Diazepam; Dioxanes; Dioxins; Idazoxan; Male; Rats; Rats, Inbred Strains | 1989 |
Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Buspirone; Clonazepam; Diazepam; Drug Combinations; Fear; Female; Humans; Male; Middle Aged; Panic; Phobic Disorders | 1989 |
Motor phenomena in benzodiazepine withdrawal.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Diagnosis, Differential; Diazepam; Drug Therapy, Combination; Female; Humans; Muscle Rigidity; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Triazolam; Urinary Incontinence | 1989 |
Alprazolam but not diazepam protects hamsters with heart disease from the medical consequences of stress.
Topics: Alprazolam; Animals; Behavior, Animal; Cardiomyopathies; Cold Temperature; Cricetinae; Diazepam; Mesocricetus; Restraint, Physical; Stress, Physiological | 1989 |
The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Diazepam; Double-Blind Method; Fear; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Random Allocation | 1989 |
Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration.
Topics: Alprazolam; Animals; Conflict, Psychological; Diazepam; Drug Administration Schedule; Injections, Intraperitoneal; Male; Motivation; Rats; Rats, Inbred Strains; Reference Values; Water Deprivation | 1989 |
Peripheral, but not local or intracerebroventricular, administration of benzodiazepines attenuates evoked activity of locus coeruleus neurons.
Topics: Action Potentials; Alprazolam; Animals; Benzodiazepines; Chlordiazepoxide; Diazepam; Dose-Response Relationship, Drug; Injections, Intraventricular; Locus Coeruleus; Male; Rats; Rats, Inbred Strains | 1989 |
Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Biogenic Amines; Body Weight; Brain Chemistry; Choice Behavior; Depressive Disorder; Diazepam; Feeding Behavior; Humans; Male; Neurotransmitter Agents; Olfactory Bulb; Phenobarbital; Rats; Rats, Inbred Strains | 1985 |
Drugs in dentistry. Agents for anxiety disorders.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Chlordiazepoxide; Clorazepate Dipotassium; Dental Care; Diazepam; Humans; Oxazepam | 1985 |
Alprazolam withdrawal delirium unresponsive to diazepam: case report.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Delirium; Diazepam; Half-Life; Humans; Male; Receptors, GABA-A; Substance Withdrawal Syndrome | 1985 |
Does alprazolam, in contrast to diazepam, activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion?
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Clonidine; Diazepam; Dioxanes; Growth Hormone; Idazoxan; Kinetics; Male; Rats; Receptors, Adrenergic, alpha; Reserpine; Yohimbine | 1986 |
Chronic use of benzodiazepines and psychomotor and cognitive test performance.
Topics: Adult; Affect; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clorazepate Dipotassium; Cognition Disorders; Diazepam; Female; Flicker Fusion; Humans; Lorazepam; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Psychomotor Disorders | 1986 |
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine; Diazepam; Double-Blind Method; Fear; Humans; Lactates; Lactic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Mitral Valve Prolapse; Panic | 1987 |
Comparative pharmacodynamics of benzodiazepines.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Triazolam | 1987 |
Alprazolam dependence in mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Diazepam; Male; Mice; Models, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1987 |
Preference for alprazolam over diazepam.
Topics: Alprazolam; Attitude; Diazepam; Humans; Risk Factors; Substance-Related Disorders | 1989 |
Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines.
Topics: Alprazolam; Animals; Benzodiazepines; Desipramine; Diazepam; Electroshock; Flumazenil; Haloperidol; Male; Rats; Rats, Inbred Strains; Ultrasonics; Vocalization, Animal | 1988 |
Increased central noradrenergic activity during benzodiazepine withdrawal: an electrophysiological study.
Topics: Action Potentials; Alprazolam; Animals; Cerebellum; Diazepam; Lorazepam; Norepinephrine; Purkinje Cells; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1988 |
The abnormal open-field behavior of SART-stressed rats and effects of some drugs on it.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Chlorpromazine; Diazepam; Dibenzazepines; Imipramine; Male; Motor Activity; Polysaccharides; Rats; Rats, Inbred Strains; Stress, Physiological | 1988 |
The anxiolytic action of benzodiazepines is not present in handling-habituated rats.
Topics: Alprazolam; Animals; Avoidance Learning; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Handling, Psychological; Male; Rats; Rats, Inbred Strains; Touch | 1988 |
The seeking and liking potentials of alprazolam.
Topics: Adult; Alprazolam; Diazepam; Female; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
Triazolam withdrawal.
Topics: Alprazolam; Diazepam; Drug Tolerance; Humans; Seizures; Substance Withdrawal Syndrome; Triazolam | 1988 |
Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets.
Topics: Alprazolam; Binding, Competitive; Blood Platelets; Diazepam; Humans; In Vitro Techniques; Kinetics; Platelet Activating Factor; Platelet Aggregation; Triazolam | 1987 |
Alprazolam withdrawal.
Topics: Adult; Alprazolam; Diazepam; Humans; Male; Substance Withdrawal Syndrome | 1987 |
Effect of chronic administration of alprazolam and adinazolam on clonidine- or apomorphine-induced aggression in laboratory rodents.
Topics: Aggression; Alprazolam; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Clonidine; Desipramine; Diazepam; Drug Interactions; Male; Mice; Rats; Rats, Inbred Strains | 1986 |
Determination of biological activity of alprazolam, triazolam and their metabolites.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Binding, Competitive; Brain; Diazepam; Flunitrazepam; Kinetics; Male; Membranes; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, GABA-A; Triazolam | 1982 |
Benzodiazepine receptor number after acute administration of alprazolam and diazepam.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Binding, Competitive; Brain; Diazepam; Flunitrazepam; In Vitro Techniques; Kinetics; Male; Membranes; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, GABA-A | 1982 |
Alprazolam in a biochemical model of depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Depression; Diazepam; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Imipramine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine | 1982 |
Benzodiazepines: drug discrimination and physiological dependence.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Bromazepam; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Humans; Lorazepam; Papio; Pentobarbital; Substance Withdrawal Syndrome; Substance-Related Disorders; Triazolam | 1984 |
Role of beta-adrenergic receptors in the antidepressant activity of alprazolam.
Topics: Alprazolam; Animals; Antidepressive Agents; Benzodiazepines; Diazepam; Dihydroalprenolol; Female; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine | 1982 |
Propranolol interactions with diazepam, lorazepam, and alprazolam.
Topics: Adolescent; Adult; Alprazolam; Benzodiazepines; Biotransformation; Chromatography, High Pressure Liquid; Diazepam; Drug Interactions; Female; Humans; Injections, Intravenous; Kinetics; Lorazepam; Male; Nordazepam; Propranolol | 1984 |
Effects of psychoactive drugs on plasma catecholamines during stress in rats.
Topics: Alprazolam; Amphetamine; Animals; Benzodiazepines; Diazepam; Epinephrine; Humans; Male; Morphine; Norepinephrine; Pentobarbital; Psychotropic Drugs; Rats; Rats, Inbred Strains; Stress, Psychological; Time Factors | 1984 |
In vitro method for detecting precipitation of parenteral formulations after injection.
Topics: Alprazolam; Benzodiazepines; Chemical Precipitation; Chemistry, Pharmaceutical; Diazepam; Injections; Solubility; Solutions | 1983 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorder; Diazepam; Dopamine beta-Hydroxylase; Double-Blind Method; Female; Humans; Imipramine; Longitudinal Studies; Male; Middle Aged | 1984 |
Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.
Topics: Administration, Oral; Alprazolam; Animals; Behavior, Animal; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Female; Flumazenil; Flunitrazepam; Male; Muscle Relaxation; Oxazepam; Saimiri; Sleep; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1995 |
Effects of desipramine and alprazolam on forced swimming behaviour of adult rats exposed to prenatal diazepam.
Topics: Alprazolam; Animals; Behavior, Animal; Depression; Desipramine; Diazepam; Electroencephalography; Electrophysiology; Female; Hippocampus; Injections; Locus Coeruleus; Male; Motor Activity; Picrotoxin; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptors, GABA; Swimming | 1995 |
Identification of parent benzodiazepines by gas chromotography/mass spectroscopy (GC/MS) from urinary extracts treated with B-glucuronidase.
Topics: Alprazolam; Benzodiazepines; Chlordiazepoxide; Clonazepam; Diazepam; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Lorazepam; Oxazepam; Triazolam | 1995 |
Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.
Topics: Adult; Alprazolam; Diazepam; Dose-Response Relationship, Drug; Drug Tolerance; Female; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Male; Memory, Short-Term; Panic Disorder; Receptors, GABA-A; Saccades | 1995 |
Alprazolam modifies animal behaviour on elevated plus-maze.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Learning; Mice; Mice, Inbred BALB C; Substance-Related Disorders | 1993 |
Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity.
Topics: Alprazolam; Animals; Benzodiazepines; Brain; Corticotropin-Releasing Hormone; Diazepam; Injections, Intraventricular; Killer Cells, Natural; Male; Pituitary-Adrenal System; Rats; Rats, Wistar | 1993 |
Characterization of the binding and comparison of the distribution of benzodiazepine receptors labeled with [3H]diazepam and [3H]alprazolam.
Topics: Alprazolam; Animals; Autoradiography; Brain; Diazepam; In Vitro Techniques; Male; Radioligand Assay; Rats; Receptors, GABA-A; Tritium | 1993 |
The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; GABA-A Receptor Agonists; Male; Motor Activity; Rats; Rats, Sprague-Dawley | 1996 |
Catatonia after benzodiazepine withdrawal.
Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Catatonia; Clonazepam; Diazepam; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome | 1996 |
Use of benzodiazepines in elderly patients.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Diazepam; Drug Utilization; Half-Life; Humans | 1996 |
Behavioural responsiveness to picrotoxin and desipramine in adult rats prenatally exposed to different benzodiazepine receptor agonists.
Topics: Adrenergic Uptake Inhibitors; Alprazolam; Animals; Behavior, Animal; Desipramine; Diazepam; Female; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; Hypnotics and Sedatives; Male; Picrotoxin; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Wistar; Seizures; Zolpidem | 1995 |
Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Conflict, Psychological; Diazepam; Male; Maze Learning; Memory; Mice; Triazolam | 1997 |
Ultrasonic vocalizations in rat pups: modulation at the gamma-aminobutyric acidA receptor complex and the neurosteroid recognition site.
Topics: Alprazolam; Animals; Diazepam; Female; Male; Muscimol; Pentobarbital; Pregnanolone; Rats; Receptors, GABA-A; Vocalization, Animal | 1997 |
Alprazolam, diazepam, yohimbine, clonidine: in vivo CA1 hippocampal norepinephrine and serotonin release profiles under chloral hydrate anesthesia.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Anesthetics, Intravenous; Animals; Anti-Anxiety Agents; Anxiety; Chloral Hydrate; Clonidine; Diazepam; Hippocampus; Male; Microelectrodes; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors; Yohimbine | 1997 |
Locomotor and antidepressant-like effects of 5-HT(1A) agonist LY 228729 in prenatally benzodiazepine-exposed rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Depressive Disorder; Diazepam; Ergolines; Female; Injections, Subcutaneous; Male; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Stereotyped Behavior; Swimming | 1998 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids; Diazepam; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Panic Disorder; Phobic Disorders | 1998 |
A new approach to the light/dark test procedure in mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Carbolines; Central Nervous System Stimulants; Diazepam; GABA Antagonists; Male; Mice; Mice, Inbred C57BL; Motor Activity | 1998 |
Determination of benzodiazepines in human urine and plasma with solvent modified solid phase micro extraction and gas chromatography; rationalisation of method development using experimental design strategies.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Chromatography, Gas; Diazepam; Flunitrazepam; Humans; Hydrogen-Ion Concentration; Models, Chemical; Nordazepam; Oxazepam; Research Design | 1998 |
A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.
Topics: Acoustic Stimulation; Alprazolam; Animals; Anti-Anxiety Agents; Cognition; Conflict, Psychological; Diazepam; Dose-Response Relationship, Drug; Electroshock; Epilepsy; Fear; Humans; Imidazoles; Male; Maze Learning; Nociceptin Receptor; Pain; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Recombinant Proteins; Reflex, Startle; Seizures; Self Stimulation; Spiro Compounds | 2000 |
Oral sedation allows for comfort and amnesia during office surgery.
Topics: Acetaminophen; Adult; Alprazolam; Ambulatory Surgical Procedures; Amnesia; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthetics, Local; Anti-Anxiety Agents; Antibiotic Prophylaxis; Conscious Sedation; Diazepam; Epinephrine; Female; Humans; Hydrocodone; Lidocaine; Male; Plastic Surgery Procedures; Treatment Outcome; Vasoconstrictor Agents | 2000 |
Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Azabicyclo Compounds; Diazepam; Dose-Response Relationship, Drug; Electroshock; Hypnotics and Sedatives; Isomerism; Male; Motor Activity; Motor Skills; Piperazines; Rats; Rats, Long-Evans; Seizures | 2001 |
Electrospray ionization gas-phase electrophoresis under ambient conditions and it's potential or high-speed separations.
Topics: Alprazolam; Anti-Anxiety Agents; Combinatorial Chemistry Techniques; Diazepam; Electrophoresis; Equipment Design; Herbicides; Nitrazepam; Oxazepam; Prazepam; Time Factors; Triazines | 2001 |
What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Diazepam; Drug Administration Schedule; Female; Humans | 1998 |
[Does the addition of an anxiolytic drug improve the anti-emetic effectiveness of the steroid and granisetron combination in the prophylaxis of cisplatin-induced vomiting?].
Topics: Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Diazepam; Droperidol; Drug Administration Schedule; Drug Therapy, Combination; Female; Genital Neoplasms, Female; Granisetron; Humans; Meprobamate; Middle Aged; Treatment Outcome; Vomiting | 2001 |
Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys.
Topics: Administration, Oral; Alprazolam; Animals; Anti-Anxiety Agents; Diazepam; Macaca mulatta; Male; Reinforcement, Psychology; Self Administration; Triazolam | 2002 |
GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Diazepam; Ethanol; Fever; Flumazenil; GABA Antagonists; Hypnotics and Sedatives; Male; Maze Learning; Mice; Mice, Knockout; Pentylenetetrazole; Phenobarbital; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex; Species Specificity; Stress, Physiological | 2002 |
Prenatal exposure to diazepam and alprazolam, but not to zolpidem, affects behavioural stress reactivity in handling-naïve and handling-habituated adult male rat progeny.
Topics: Age Factors; Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Convulsants; Diazepam; Exploratory Behavior; Female; GABA Agonists; Habituation, Psychophysiologic; Handling, Psychological; Male; Picrotoxin; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Wistar; Reflex; Reflex, Startle; Stress, Physiological; Swimming; Zolpidem | 2002 |
Detection of the adulteration of traditional alcoholic beverages by the separation and determination of alprazolam, chloralhydrate and diazepam using reversed-phase high-performance liquid chromatography.
Topics: Alcoholic Beverages; Alprazolam; Chloral Hydrate; Chromatography, High Pressure Liquid; Diazepam; Reference Standards; Sensitivity and Specificity | 2004 |
Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats.
Topics: Acoustic Stimulation; Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Buspirone; Diazepam; Electromagnetic Fields; Male; Motor Activity; Rats; Rats, Wistar | 2005 |
Prescription drug abuse among ecstasy users in Miami.
Topics: Adolescent; Adult; Alprazolam; Catchment Area, Health; Diazepam; Drug Prescriptions; Ethnicity; Female; Florida; Humans; Hydrocodone; Male; N-Methyl-3,4-methylenedioxyamphetamine; Oxycodone; Substance-Related Disorders; Surveys and Questionnaires | 2005 |
Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Brain Chemistry; Diazepam; Electron Transport Complex IV; Emotions; GABA Modulators; Hypnotics and Sedatives; Immunohistochemistry; Limbic System; Male; Motor Activity; Neurons; Oxidation-Reduction; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Zolpidem | 2006 |
The detection of sedatives in hair and nail samples using tandem LC-MS-MS.
Topics: Adult; Aged; Aged, 80 and over; Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Clobazam; Clonazepam; Diazepam; Female; Forensic Pathology; Hair; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Midazolam; Middle Aged; Nails; Oxazepam; Piperazines; Predictive Value of Tests; Rape; Temazepam; Triazolam | 2007 |
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes.
Topics: Alprazolam; Animals; Benzodiazepines; Diazepam; Flumazenil; Male; Pyridines; Receptors, GABA-A; Saimiri; Sucrose; Zolpidem | 2006 |
Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines.
Topics: Alprazolam; Benzodiazepines; Cell Survival; Cells, Cultured; Cryopreservation; Cytochrome P-450 CYP3A; Diazepam; Flunitrazepam; Hepatocytes; Humans; Metabolic Clearance Rate; Microsomes, Liver; Midazolam; Substrate Specificity; Triazolam | 2008 |
Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion.
Topics: Alprazolam; Benzodiazepines; Chemistry, Pharmaceutical; Clonazepam; Diazepam; Drug Carriers; Drug Compounding; Fat Emulsions, Intravenous; Hydrogen-Ion Concentration; Lorazepam; Molecular Structure; Particle Size; Phospholipids; Solubility; Soybean Oil; Technology, Pharmaceutical; Ultracentrifugation | 2008 |
Adverse effects of benzodiazepines in psychiatric outpatients.
Topics: Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Benzodiazepines; Croatia; Diazepam; Drug Therapy, Combination; Drug Utilization; Female; Humans; Hypnotics and Sedatives; Male; Mental Disorders; Patient Compliance; Surveys and Questionnaires | 2009 |
Microemulsion based intranasal delivery system for treatment of insomnia.
Topics: Administration, Intranasal; Alprazolam; Animals; Diazepam; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Humans; Lorazepam; Male; Rats; Rats, Sprague-Dawley; Sleep; Sleep Initiation and Maintenance Disorders | 2009 |
[Simultaneous determination of 5 sedative hypnotics in human plasma by reversed phase high-performance liquid chromatography].
Topics: Alprazolam; Chromatography, High Pressure Liquid; Diazepam; Estazolam; Humans; Hypnotics and Sedatives; Nitrazepam; Oxazepam | 2009 |
Quantitation of benzodiazepines in blood and urine using gas chromatography-mass spectrometry (GC-MS).
Topics: Alprazolam; Benzodiazepines; Diazepam; Gas Chromatography-Mass Spectrometry; Humans; Lorazepam; Nordazepam; Oxazepam; Solid Phase Extraction; Triazolam | 2010 |
Cytogenetic activity of newly synthesized 1,5-benzodiazepines in normal human lymphocyte cultures.
Topics: Adult; Alprazolam; Benzodiazepines; Cell Proliferation; Cells, Cultured; Cytogenetic Analysis; Diazepam; Humans; Lorazepam; Lymphocytes; Mitotic Index; Sister Chromatid Exchange | 2010 |
Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests.
Topics: Adaptation, Ocular; Alprazolam; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Locomotion; Male; Maze Learning; Mice; Mice, Inbred Strains; Species Specificity; Weights and Measures | 2010 |
Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression.
Topics: Alprazolam; Animals; Antibodies, Viral; Antibody Formation; Apoptosis; Body Weight; Cell Proliferation; Cells, Cultured; Cowpox virus; Diazepam; Female; Humans; Immune Tolerance; Mice; Mice, Inbred BALB C; Poxviridae Infections; Spleen; Vaccinia virus | 2010 |
Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Benzodiazepines; Chlordiazepoxide; Diazepam; Dose-Response Relationship, Drug; Fear; GABA Modulators; Male; Mice; Mice, Inbred C57BL; Receptors, GABA-A; Reflex, Startle | 2011 |
A comparative study on the cytogenetic activity of three benzodiazepines in vitro.
Topics: Adult; Alprazolam; Benzodiazepines; Cells, Cultured; Chromosome Aberrations; Diazepam; DNA Damage; DNA Repair; Humans; Lorazepam; Lymphocytes; Mutagens; Sister Chromatid Exchange | 2011 |
Role of α1- and α2-GABA(A) receptors in mediating the respiratory changes associated with benzodiazepine sedation.
Topics: Alprazolam; Animals; Diazepam; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Hypnotics and Sedatives; Injections, Intraperitoneal; Mice; Mice, Mutant Strains; Plethysmography, Whole Body; Point Mutation; Receptors, GABA-A; Respiration; Time Factors | 2012 |
Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults.
Topics: Aged; Aged, 80 and over; Alprazolam; Causality; Cohort Studies; Cross-Sectional Studies; Diazepam; Female; Fractures, Bone; Health Surveys; Hip Fractures; Hospitalization; Humans; Hypnotics and Sedatives; Joint Dislocations; Lorazepam; Male; Odds Ratio; Pyridines; Retrospective Studies; Risk; Statistics as Topic; Zolpidem | 2011 |
Ethopharmacological evaluation of the rat exposure test: a prey-predator interaction test.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Diazepam; Escape Reaction; Factor Analysis, Statistical; Fluoxetine; Food Chain; Imipramine; Male; Mice; Motor Activity; Posture; Predatory Behavior; Rats; Rats, Long-Evans; Time Factors; Yohimbine | 2013 |
Ethopharmacological analysis of the open elevated plus-maze in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Convulsants; Corticosterone; Diazepam; Factor Analysis, Statistical; Fluoxetine; Male; Maze Learning; Mice; Pentylenetetrazole; Statistics, Nonparametric; Yohimbine | 2013 |
Dependence of the kinetic and thermodynamic parameters on hydrophilic-lipophilic character of alprazolam, clonazepam, diazepam, doxepin and haloperidol in alkaline environment.
Topics: Alprazolam; Clonazepam; Diazepam; Doxepin; Drug Stability; Haloperidol; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Thermodynamics | 2013 |
The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice.
Topics: Alprazolam; Animals; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Hypokinesia; Imipramine; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pyridines; Stress, Psychological; Swimming; Time Factors; Vigabatrin; Zolpidem | 2014 |
[Cross-reactivity of Instant-View M-1 for detection of benzodiazepine-related drugs and their metabolites in urine].
Topics: Alprazolam; Benzodiazepines; Biomarkers; Cross Reactions; Diazepam; Humans; Immunoassay; Nitrazepam; Reagent Kits, Diagnostic; Sensitivity and Specificity; Structure-Activity Relationship; Substance Abuse Detection; Triazolam | 2014 |
A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: determination of MDPV metabolites by LC-HRMS and discussion of the case.
Topics: Adult; Alprazolam; Benzodiazepines; Benzodioxoles; Chlordiazepoxide; Chromatography, Liquid; Diazepam; Humans; Hypnotics and Sedatives; Male; Mass Spectrometry; Nordazepam; Oxazepam; Psychotropic Drugs; Pyrrolidines; Substance-Related Disorders; Synthetic Cathinone; Temazepam | 2014 |
Detection Times of Diazepam, Clonazepam, and Alprazolam in Oral Fluid Collected From Patients Admitted to Detoxification, After High and Repeated Drug Intake.
Topics: Adult; Alprazolam; Chromatography, High Pressure Liquid; Clonazepam; Diazepam; Female; Humans; Male; Middle Aged; Saliva; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Time Factors; Young Adult | 2015 |
Development of an ultra-high-performance liquid chromatography coupled to high-resolution quadrupole-Orbitrap mass spectrometry method for the rapid detection and confirmation of illegal adulterated sedative-hypnotics in dietary supplements.
Topics: Alprazolam; Chromatography, High Pressure Liquid; Clonazepam; Diazepam; Dietary Supplements; Drug Contamination; Food Safety; Humans; Hypnotics and Sedatives; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry | 2015 |
Development of a Paper Spray Mass Spectrometry Cartridge with Integrated Solid Phase Extraction for Bioanalysis.
Topics: Alprazolam; Animals; Atenolol; Carbamazepine; Cattle; Diazepam; Mass Spectrometry; Paper; Solid Phase Extraction; Sulfamethazine | 2015 |
Hypothesis: A single dose of an anxiolitic may prevent unnecessary visits to the emergency room during blood pressure elevations.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Captopril; Diazepam; Emergency Medicine; Emergency Service, Hospital; Humans; Hypertension; Models, Theoretical; Risk | 2016 |
Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug Use.
Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Antipsychotic Agents; Australia; Benzodiazepines; Diazepam; Drug and Narcotic Control; Drug Substitution; Female; Humans; Hypnotics and Sedatives; Interrupted Time Series Analysis; Male; Middle Aged; Oxazepam; Practice Patterns, Physicians' | 2016 |
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Diazepam; Dog Diseases; Dogs; Fear; Fluoxetine; Gabapentin; Male; Noise; Paroxetine; Phobic Disorders | 2017 |
An Experimental Study of Diazepam and Alprazolam Kinetics in Urine and Oral Fluid Following Single Oral Doses.
Topics: Administration, Oral; Adult; Alprazolam; Diazepam; Female; Healthy Volunteers; Humans; Kinetics; Male; Saliva; Time Factors; Young Adult | 2019 |
GABA
Topics: Allosteric Regulation; Alprazolam; Benzodiazepines; Bicuculline; Binding, Competitive; Cryoelectron Microscopy; Diazepam; GABA Modulators; Humans; Ligands; Models, Molecular; Nanostructures; Picrotoxin; Receptors, GABA-A; Signal Transduction | 2019 |
Increased sensitivity to psychostimulants and GABAergic drugs in Lsamp-deficient mice.
Topics: Alprazolam; Animals; Behavior, Animal; Cell Adhesion Molecules, Neuronal; Central Nervous System Depressants; Central Nervous System Stimulants; Cocaine; Diazepam; Disease Models, Animal; Dizocilpine Maleate; Ethanol; Female; GABA Modulators; Gene Knockout Techniques; GPI-Linked Proteins; Locomotion; Male; Maze Learning; Mice; Mice, Knockout; Morphine; Neuroprotective Agents; Phenotype; Receptors, GABA-A | 2019 |
Nonmedical use of alprazolam in the UK: Results from a nationally representative survey.
Topics: Adolescent; Adult; Age Factors; Aged; Alprazolam; Central Nervous System Stimulants; Child; Cross-Sectional Studies; Diazepam; Female; Humans; Male; Middle Aged; Motivation; Prescription Drug Misuse; Prevalence; Surveys and Questionnaires; United Kingdom; Young Adult | 2019 |
Dried blood spots sampling in case samples deprived of hematocrit level information - Investigation and calculation strategy.
Topics: Alprazolam; Bone Marrow; Diazepam; Dried Blood Spot Testing; Hematocrit; Humans; Psychotropic Drugs | 2019 |
Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
Topics: Adult; Aged; Alprazolam; Benzodiazepines; Cross-Sectional Studies; Diazepam; Executive Function; Female; HIV Infections; Humans; Lorazepam; Male; Memory, Short-Term; Mental Recall; Mental Status and Dementia Tests; Middle Aged; Motor Skills; Neurocognitive Disorders; Propensity Score; Retrospective Studies; Self Report; Young Adult | 2019 |
Postmortem Analysis of Benzodiazepines in Human Bone by Gas Chromatography-Mass Spectrometry.
Topics: Alprazolam; Autopsy; Benzodiazepines; Chromatography, Liquid; Clonazepam; Diazepam; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Liquid-Liquid Extraction; Lorazepam; Nordazepam; Oxazepam; Tandem Mass Spectrometry | 2021 |
The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine.
Topics: Alprazolam; Caffeine; Counterfeit Drugs; Diazepam; Fatal Outcome; Humans; Male; Middle Aged | 2020 |
Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction.
Topics: Alprazolam; Azabicyclo Compounds; Benzodiazepines; Chromatography, Liquid; Diazepam; Forensic Toxicology; Humans; Hypnotics and Sedatives; Limit of Detection; Piperazines; Sleep Aids, Pharmaceutical; Solid Phase Extraction; Substance Abuse Detection; Tandem Mass Spectrometry; Zolpidem | 2020 |
Is the unique benzodiazepine structure interacting with CYP enzymes to affect steroid synthesis in vitro?
Topics: Adrenal Cortex Hormones; Adrenal Glands; Alprazolam; Androgens; Benzodiazepines; Diazepam; Endocrine Disruptors; Humans; Molecular Docking Simulation; Oxazepam; Receptors, Androgen; Receptors, GABA-A; Steroid 17-alpha-Hydroxylase; Steroid 21-Hydroxylase; Steroids | 2021 |
Optimized Photo-Fenton degradation of psychoactive pharmaceuticals alprazolam and diazepam using a chemometric approach-Structure and toxicity of transformation products.
Topics: Alprazolam; Diazepam; Hydrogen Peroxide; Oxidation-Reduction; Pharmaceutical Preparations; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2021 |
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic.
Topics: Alprazolam; Benzodiazepines; Clonazepam; COVID-19; Diazepam; Humans; Ketamine; Lorazepam; Mexico; Nordazepam; Pandemics; Tandem Mass Spectrometry; Temazepam; United States; Wastewater; Zolpidem | 2023 |
Drug prescriptions preceding opioid-related deaths-a register study in forensic autopsy patients.
Topics: Alprazolam; Analgesics, Opioid; Autopsy; Diazepam; Drug Overdose; Drug Prescriptions; Humans; Opioid-Related Disorders; Prescriptions; Retrospective Studies; Substance-Related Disorders | 2023 |